Right now, in the United States alone, there are more than 1,000 clinical trials testing new treatments, medications and therapeutic strategies to fight prostate cancer, according to the Prostate Cancer Foundation.
And there are many more on-going trials for prostate cancer stretching worldwide, across the entire globe. While some of the trials are in their infancy and some are small, others are larger scale and closer to FDA approval.
Areas of research include new combination treatments, new drugs, the application of therapies used to treat other cancers that may be used to prostate cancer, new immunotherapies and new hormonal treatments. Researchers are also studying genetic biomarkers, predictive models for progression and recurrence and ways to enhance diagnostic tools.
In fact, there are more than 230 companies researching more than 265 new medications according to the Prostate Cancer Competitive Landscape, 2026.
While there is never a good time to be diagnosed with prostate cancer, in 2026 there are more ways to treat the disease with higher success rates, especially when the cancer is caught early.
The five-year survival rate in the United States for men who are diagnosed with early-stage prostate cancer, when the disease is easier to treat, is 99%, making a man’s chance of dying from prostate cancer about 1% according to the Prostate Cancer Foundation.
CyberKnife: The Gold Standard for Prostate Cancer Treatment
While researchers continuously search for new treatments, if you are diagnosed with prostate cancer, you have treatment options – including radiation therapy with CyberKnife, which uses a form of targeted radiation known as stereotactic body radiation therapy or SBRT.
“Years of mounting research is proving CyberKnife to be the gold standard for treating prostate cancer, and as more men learn about CyberKnife, it is becoming the number one treatment of choice,” says Dr. Mark Pomper, board-certified radiation oncologist and medical director of the CyberKnife Center of Miami.
Dr. Pomper says CyberKnife has distinct benefits for treating prostate cancer.
- CyberKnife treatments can be done in five radiation therapy sessions over 10 days compared to 42 over three months with other types of radiation treatments.
- Treatments are outpatient and last 30 to 60 minutes.
- The CyberKnife radiation beams, which target and destroy the tumor, are so precise that healthy tissue is left unharmed so there is a lower risk of side effects including impotence and incontinence.
- CyberKnife is noninvasive so there are no risks of infection or long periods of downtime like there is with surgery.
- Side effects are minimal, if any at all.
- Patients can be treated repeatedly with CyberKnife.
- Most patients tolerate CyberKnife treatment very well.
- Plus, CyberKnife has a very high success rate treating prostate cancer, according to CyberKnife Miami, about 95% when detected early.
CyberKnife alone can treat prostate cancer, especially if it’s low grade and localized to the prostate cancer.
For these early prostate cancers, cure rates with radiation are about the same as men treated with radical prostatectomy, which is surgery to remove the prostate gland and may cause long-term issues for a man’s urinary and sexual health, according to the American Cancer Society.
For patients with metastatic prostate cancer, ones who can’t have surgery, failed other treatments or have been told there’s nothing left to do – CyberKnife can also be a viable treatment.
Prostate Cancer Treatment Near Me
At CyberKnife Miami we treat all prostate cancers — from early to metastatic prostate cancers. Since we are among the most experienced teams using CyberKnife technology, we have a high success rate, and aren’t afraid to take on even the most difficult cases.
We will let you know upfront, if CyberKnife is the best treatment option for your particular case, or if it is not. We put patients first. That means we will help guide you, but the final decision is your’s. We will help educate you, so you are confident in whatever treatment you choose.
If you are diagnosed with prostate cancer and want a second opinion, which is always a good idea, feel free to call CyberKnife Miami at 305-279-2900, or to set up a consultation. And go to our prostate cancer website now for more information and to see patient testimonials.